C36H39N11O7S — CID 160825309
N-[7-butoxy-5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)imino-[1,3]thiazolo[4,5-b]pyrazin-3-yl]but-2-enyl]benzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide (PubChem CID 160825309) has the molecular formula C36H39N11O7S and a molecular weight of 769.84 g/mol. Its IUPAC name is N-[7-butoxy-5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)imino-[1,3]thiazolo[4,5-b]pyrazin-3-yl]but-2-enyl]benzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide.
| Compound Name | N-[7-butoxy-5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)imino-[1,3]thiazolo[4,5-b]pyrazin-3-yl]but-2-enyl]benzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide |
|---|---|
| PubChem CID | 160825309 |
| Molecular Formula | C36H39N11O7S |
| Molecular Weight | 769.84 g/mol |
| Exact Mass | 769.28 |
| IUPAC Name | N-[7-butoxy-5-carbamoyl-1-[(E)-4-[6-carbamoyl-2-(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)imino-[1,3]thiazolo[4,5-b]pyrazin-3-yl]but-2-enyl]benzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide |
| SMILES | CCCCOc1cc(C(N)=O)cc2nc(NC(=O)c3oc(C)nc3CC)n(C/C=C/Cn3/c(=N/C(=O)c4oc(C)nc4CC)sc4nc(C(N)=O)cnc43)c12 |
| InChI | InChI=1S/C36H39N11O7S/c1-6-9-14-52-25-16-20(29(37)48)15-23-26(25)46(35(43-23)44-32(50)27-21(7-2)40-18(4)53-27)12-10-11-13-47-31-34(42-24(17-39-31)30(38)49)55-36(47)45-33(51)28-22(8-3)41-19(5)54-28/h10-11,15-17H,6-9,12-14H2,1-5H3,(H2,37,48)(H2,38,49)(H,43,44,50)/b11-10+,45-36- |
| InChIKey | SMYHKEXUQSIYKK-YZLXVUBGSA-N |
| XLogP | 4.19 |
| TPSA | 254.53 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 55 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 769.84 |
| LogP ≤ 5 | 4.19 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 15 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|